Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin

Oncogene

Volumn 28, Issue 38, 2009, Pages 3401-3411

  Wan, X ^a,d   Kim, S Y ^a   Guenther, L M ^a   Mendoza, A ^a   Briggs, J ^a   Yeung, C ^a   Currier, D ^a   Zhang, H ^a   MacKall, C ^a   Li, W J ^b   Tuan, R S ^b   Deyrup, A T ^c   Khanna, C ^a   Helman, L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

B4 integrin; Ezrin; Interaction; Metastases; Osteosarcoma

Indexed keywords

BETA4 INTEGRIN; EZRIN; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION;

BONE NEOPLASMS; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; HUMANS; INTEGRIN BETA4; OSTEOSARCOMA;

EID: 70349440966     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.206     Document Type: Article

References (39)

1. Andreoli C, Martin M, Le Borgne R, Reggio H, Mangeat P. (1994). Ezrin has properties to self-associate at the plasma membrane. J Cell Sci 107: 2509-2521.
2. Aplin AE, Howe AK, Juliano RL. (1999). Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol 11: 737-744.
3. Bertotti A, Comoglio PM, Trusolino L. (2005). Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis. Cancer Res 65: 10674-10679.
4. Bertotti A, Comoglio PM, Trusolino L. (2006). Beta4 integrin activates a Shp2-Src signaling pathway that sustains HGF-induced anchorage-independent growth. J Cell Biol 175: 993-1003.
5. Calderwood DA, Fujioka Y, de Pereda JM, Garcia-lvarez B, Nakamoto T, Margolis B et al. (2003). Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc Natl Acad Sci USA 100: 2272-2277.
6. Calderwood DA, Huttenlocher A, Kiosses WB, Rose DM, Woodside DG, Schwartz MA et al. (2001). Increased filamin binding to beta-integrin cytoplasmic domains inhibits cell migration. Nat Cell Biol 3: 1060-1068.
7. Calderwood DA, Zent R, Grant R, Rees DJ, Hynes RO, Ginsberg MH. (1999). The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 274: 28071-28074.
8. Chung J, Bachelder RE, Lipscomb EA, Shaw LM, Mercurio AM. (2002). Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol 158: 165-174.
9. Gaffney R, Unni KK, Sim FH, Slezak JM, Esther RJ, Bolander ME. (2006). Follow-up study of long-term survivors of osteosarcoma in the prechemotherapy era. Hum Pathol 244: 799-804.
10. Geiger B, Bershadsky A, Pankov R, Yamada KM. (2001). Transmem-brane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2: 793-805.
11. Giancotti FG, Ruoslahti E. (1999). Integrin signaling. Science 285: 1028-1032.
12. Giancotti FG, Tarone G. (2003). Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol 19: 173-206.
13. Grossman HB, Lee C, Bromberg J, Liebert M. (2000). Expression of the alpha6beta4 integrin provides prognostic information in bladder cancer. Oncol Rep 7: 13-16.
14. Guo W, Giancotti FG. (2004). Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5: 816-826.
15. Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G et al. (2006). Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126: 489-502.
16. Harris MB, Gieser P, Goorin AM, Ayala A, Shochat SJ, Ferguson WS et al. (1998). Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study. J Clin Oncol 16: 3641-3648.
17. Hood JD, Cheresh DA. (2002). Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100.
18. Howe A, Aplin AE, Alahari SK, Juliano RL. (1998). Integrin signaling and cell growth control. Curr Opin Cell Biol 10: 220-231.
19. Hynes RO. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687.
20. Kashiwagi H, Schwartz MA, Eigenthaler M, Davis KA, Ginsberg MH, Shattil SJ. (1997). Affinity modulation of platelet integrin alphaIIbbeta3 by beta3-endonexin, a selective binding partner of the beta3 integrin cytoplasmic tail. J Cell Biol 137: 1433-1443.
21. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A et al. (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10: 182-186.
22. Kim SY, Lee CH, Midura BV, Yeung C, Mendoza A, Hong SH et al. (2008). Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis 25: 201-211.
23. Kolanus W, Nagel W, Schiller B, Zeitlmann L, Godar S, Stockinger H et al. (1996). Alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule. Cell 86: 233-242.
24. Liu S, Calderwood DA, Ginsberg MH. (2002). Integrin cytoplasmic domain-binding proteins. J Cell Sci 113: 3563-3571.
25. Liu XF, Helman LJ, Yeung C, Bera TK, Lee B, Pastan I. (2000). XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma. Cancer Res 60: 4752-4755.
26. Livak KG, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 4: 402-408.
27. Lu S, Simin K, Khan A, Mercurio AM. (2008). Analysis of Integrin {beta}4 Expression in Human Breast Cancer: Association with Basal-like Tumors and Prognostic Significance. Clin Cancer Res 14: 1050-1058.
28. Mariotti A, Kedeshian PA, Dans M, Curatola AM, Gagnoux-Palacios L, Giancotti FG. (2001). EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion. J Cell Biol 155: 447-458.
29. Mercurio AM, Rabinovitz I. (2001). Towards a mechanistic understanding of tumor invasion-lessons from the a6b4integrin. Semin Cancer Biol 11: 129-141.
30. Meyers PS, Heller G, Healey G, Huvos A, Applewhite A, Sun M et al. (1993). Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 11: 449-453.
31. Nguyen R, Reczek D, Bretscher A. (2001). Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP. J Biol Chem 276: 7621-7629.
32. Nikolopoulos SN, Blaikie P, Yoshioka T, Guo W, Giancotti FG. (2004). Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell 6: 471-483.
33. Pfaff M, Du X, Ginsberg MH. (1999). Calpain cleavage of integrin beta cytoplasmic domains. FEBS Lett 460: 17-22.
34. Rhim JS, Park DK, Arnstein P, Huebner RJ, Weisburgern EK, Nelson-Rees WA. (1975). Transformation of human cells in culture by N-methyl-N0-nitro-N- nitrosoguanidine. Nature 256: 751-753.
35. Shaw LM. (2001). Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion. Mol Cell Biol 21: 5082-5093.
36. Tagliabue E, Ghirelli C, Squicciarini P, Aiello P, Colnaghi MI, Menard S. (1998). Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin Cancer Res 4: 407-410.
37. Trusolino L, Bertotti A, Comoglio PM. (2001). A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 107: 643-654.
38. Wan X, Helman LJ. (2003). Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II- overexpressing rhabdomyosarcomas cells. Oncogene 22: 8205-8211.
39. Wan X, Mendoza A, Khanna C, Helman LJ. (2005). Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma. Cancer Res 65: 2406-2411.